Barclays PLC Buys 19,245 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Barclays PLC increased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 20.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 111,689 shares of the company's stock after buying an additional 19,245 shares during the quarter. Barclays PLC owned 0.23% of Prestige Consumer Healthcare worth $8,721,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Franklin Resources Inc. grew its holdings in shares of Prestige Consumer Healthcare by 0.7% during the 4th quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock valued at $1,697,000 after purchasing an additional 150 shares during the last quarter. CIBC Private Wealth Group LLC increased its holdings in shares of Prestige Consumer Healthcare by 48.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after buying an additional 152 shares during the period. QRG Capital Management Inc. boosted its holdings in Prestige Consumer Healthcare by 3.3% during the 4th quarter. QRG Capital Management Inc. now owns 5,496 shares of the company's stock valued at $429,000 after acquiring an additional 176 shares during the period. O Shaughnessy Asset Management LLC grew its position in Prestige Consumer Healthcare by 3.0% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 7,026 shares of the company's stock worth $549,000 after acquiring an additional 207 shares during the last quarter. Finally, Summit Investment Advisors Inc. lifted its position in Prestige Consumer Healthcare by 4.2% in the fourth quarter. Summit Investment Advisors Inc. now owns 5,182 shares of the company's stock valued at $405,000 after purchasing an additional 211 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Stock Up 1.2 %

Prestige Consumer Healthcare stock traded up $0.99 on Friday, hitting $80.52. 270,919 shares of the stock traded hands, compared to its average volume of 287,807. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $90.04. The firm has a market cap of $3.99 billion, a P/E ratio of 18.86, a price-to-earnings-growth ratio of 2.69 and a beta of 0.47. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The business's fifty day simple moving average is $83.60 and its 200 day simple moving average is $80.48.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Canaccord Genuity Group upped their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a report on Friday, February 7th. DA Davidson increased their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Oppenheimer boosted their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a report on Thursday, February 13th. StockNews.com cut Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Tuesday, April 8th. Finally, Royal Bank of Canada lifted their price target on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a "sector perform" rating in a report on Friday, March 21st. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $93.33.

Insider Transactions at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. This trade represents a 8.91 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.